HamdyN.A.T., RisteliJ., RisteliL.Serum type I procollagen propeptide: A non-invasive index of bone formation in patients on haemodialysis?Nephrol Dial Transplant1994; 9: 511–16.
2.
DigenisG., DombrosN., ChristophorakiM.Procollagen type-1 in the serum and dialysate of continuous ambulatory peritoneal dialysis patients.Perit Dial Int1993; 13: S480–S483.
3.
JoffeP., JensenL.T.Type I and III procollagens in CAPD: Markers of peritoneal fibrosis. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G. eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1991; 7: 158–60.
4.
MelkkoJ., NiemiS., RisteliL., RisteliJ.Radioimmuno-assay of the carboxyterminal propeptide of human type I procollagen.Clin Chem1990; 36: 1328–32.
5.
GarneroP., GrimauxM., DemiauxB., PeraudatC., SeguinP., DelmasD.P.Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay.J Bone Miner Res1994; 7: 1389–98.
6.
StruijkD.G., KredietR.T., KoomenG.C.M., BoeschotenE.W., HoekF.J., AriszL.A prospective study of peritoneal transport in CAPD patients.Kidney Int1994; 45: 1739–44.
7.
JoffeP., HearG.J., HyldstrupL.Osteocalcin. A noninvasive index of metabolic bone disease in patients treated by CAPD.Kidney Int1994; 46: 838–46.
8.
MazzaferoS., CoenG., BallantiP.Osteocalcin, iPTH, alkaline phosphatase and hand X ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy.Nephron1990; 56: 261–6.
9.
MactierR.A., KhannaR., TwardowskiZ., MooreH., NolphK.D.Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.J Clin Invest1987; 80: 1311–16.
10.
HeimburgerO., WaniewskiJ., WerynskiA., TranaeusA., LindholmB.Peritoneal transport in CAPD patients with permanent loss orultrafiltration capacity.Kidney Int1990; 38: 495–506.
